The CDMO, which has been owned by different private investors over the last decade, will use the funds to broaden its geographic reach.

Global active pharmaceutical ingredients (API) market will reach $ 386.2 billion by 2032, growing by 6.4% annually over 2022-2032, driven by rising adoption of biologics in disease management, ...

North America active pharmaceutical ingredients (API) market is projected to grow by 4.8% annually in the forecast period and reach $120.7 billion by 2032, driven by rising adoption of biologics in ...

Catalent plans to invest an estimated $45 million to expand its facilities and purchase new equipment for its production ...

Globally, $105.3 billion worth of pharmaceuticals and biotech M&A deals have been inked so far in 2025, according to data ...

Novo Nordisk invests €2.34B to expand its Anagni facility near Rome, enhancing production of diabetes and obesity treatments ...

Plc - Director Appointment, Board Change PR Newswire LONDON, United Kingdom, July 08 8 July 20254basebio PLC("4basebio" or the "Company")Director Appointment, Board ...